Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AMIXNASDAQ:ICUNASDAQ:IRIXNASDAQ:LFWD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMIXAutonomix Medical$1.30-5.1%$1.78$1.23▼$42.40$3.61M-3.46337,821 shs173,990 shsICUSeaStar Medical$1.18-4.8%$1.25$1.11▼$13.85$12.22M-0.89264,456 shs165,685 shsIRIXIRIDEX$0.94+0.0%$1.04$0.78▼$2.41$15.78M0.6150,006 shs185,749 shsLFWDReWalk Robotics$1.10-3.5%$1.33$1.07▼$4.77$12.11M0.16696,582 shs370,074 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMIXAutonomix Medical0.00%-12.16%-31.58%-29.73%-95.39%ICUSeaStar Medical0.00%-7.09%-4.84%-41.87%-68.45%IRIXIRIDEX0.00%-3.40%-5.99%-16.81%-54.80%LFWDReWalk Robotics0.00%-9.09%-14.73%-27.15%-76.50%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAMIXAutonomix Medical2.6866 of 5 stars3.52.00.00.02.51.71.3ICUSeaStar Medical0.3393 of 5 stars0.03.00.00.01.31.70.0IRIXIRIDEX0.4915 of 5 stars0.03.00.00.02.11.70.0LFWDReWalk Robotics2.5152 of 5 stars3.53.00.00.02.50.01.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMIXAutonomix Medical 3.00Buy$16.501,169.23% UpsideICUSeaStar Medical 0.00N/AN/AN/AIRIXIRIDEX 0.00N/AN/AN/ALFWDReWalk Robotics 3.00Buy$9.00718.18% UpsideCurrent Analyst Ratings BreakdownLatest AMIX, IRIX, LFWD, and ICU Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/29/2025AMIXAutonomix MedicalMaxim GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$5.00(Data available from 6/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMIXAutonomix MedicalN/AN/AN/AN/A$8.12 per shareN/AICUSeaStar Medical$428K28.55N/AN/A($6.29) per share-0.19IRIXIRIDEX$48.80M0.32N/AN/A$0.59 per share1.59LFWDReWalk Robotics$25.41M0.48N/AN/A$5.42 per share0.20Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMIXAutonomix Medical-$15.43M-$7.47N/AN/AN/AN/A-212.48%-161.13%N/AICUSeaStar Medical-$26.23M-$3.47N/A∞N/AN/AN/A-627.49%8/11/2025 (Estimated)IRIXIRIDEX-$9.57M-$0.43N/A∞N/A-22.79%-192.95%-33.97%8/6/2025 (Estimated)LFWDReWalk Robotics-$22.13M-$3.04N/AN/AN/A-77.21%-43.02%-31.53%8/13/2025 (Estimated)Latest AMIX, IRIX, LFWD, and ICU EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/29/2025Q4 2025AMIXAutonomix MedicalN/A-$0.74N/A-$0.74N/AN/A5/15/2025Q1 2025LFWDReWalk Robotics-$0.33-$0.46-$0.13-$0.46$5.84 million$5.03 million5/14/2025Q1 2025ICUSeaStar Medical-$0.52-$0.44+$0.08-$0.44$0.15 million$0.29 million5/13/2025Q1 2025IRIXIRIDEX-$0.10-$0.10N/A-$0.10$12.10 million$11.90 million3/27/2025Q4 2024ICUSeaStar Medical-$0.89-$0.90-$0.01-$0.90$0.15 million$0.07 million3/27/2025Q4 2024IRIXIRIDEX-$0.05-$0.05N/A-$0.05$12.80 million$12.70 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAMIXAutonomix MedicalN/AN/AN/AN/AN/AICUSeaStar MedicalN/AN/AN/AN/AN/AIRIXIRIDEXN/AN/AN/AN/AN/ALFWDReWalk RoboticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMIXAutonomix MedicalN/A5.315.31ICUSeaStar MedicalN/A0.540.54IRIXIRIDEX0.551.540.85LFWDReWalk RoboticsN/A2.651.90Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMIXAutonomix Medical10.78%ICUSeaStar Medical1.69%IRIXIRIDEX20.10%LFWDReWalk Robotics26.76%Insider OwnershipCompanyInsider OwnershipAMIXAutonomix Medical32.40%ICUSeaStar Medical1.30%IRIXIRIDEX7.40%LFWDReWalk Robotics2.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAMIXAutonomix Medical12.78 million1.67 millionN/AICUSeaStar Medical210.36 million4.37 millionNot OptionableIRIXIRIDEX12016.79 million15.42 millionOptionableLFWDReWalk Robotics6011.01 million10.36 millionOptionableAMIX, IRIX, LFWD, and ICU HeadlinesRecent News About These CompaniesLifeward Appoints Mark Grant As New CEO: Retail Sentiment DipsMay 20, 2025 | msn.comLifeward Ltd.: Lifeward Names Mark Grant as New CEOMay 19, 2025 | finanznachrichten.deLongtime Medtronic leader is the new Lifeward CEOMay 19, 2025 | massdevice.comLifeward Names Mark Grant as New CEOMay 19, 2025 | globenewswire.comLifeward to Present at Sidoti Virtual Investor Conference on May 21May 19, 2025 | globenewswire.comLifeward reaffirms $28M–$30M 2025 revenue guidance as pipeline expands 70% and cost controls tightenMay 15, 2025 | msn.comLifeward (LFWD) Reports Q1 Loss, Lags Revenue EstimatesMay 15, 2025 | zacks.comLifeward Ltd. Reports First Quarter 2025 Financial ResultsMay 15, 2025 | globenewswire.comLifeward Completes Research Program with Israeli Human-Robot Interaction Consortium to Integrate Artificial Intelligence and ExoskeletonsMay 8, 2025 | globenewswire.comLifeward to Report First Quarter 2025 Financial Results on May 15, 2025May 7, 2025 | globenewswire.comFirst Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal ExoskeletonApril 29, 2025 | globenewswire.comLifeward says Israeli soldier walks again with ReWalk Personal ExoskeletonApril 24, 2025 | markets.businessinsider.comParalyzed Israeli Soldier Walks Again with Use of the ReWalk Personal ExoskeletonApril 24, 2025 | globenewswire.comLFWD Stock Falls Despite Launch of Next-Generation Mobility ReWalk 7April 16, 2025 | zacks.comLifeward launches next-gen ReWalk 7 personal exoskeleton in the U.S.April 15, 2025 | massdevice.comLifeward launches sales of ReWalk 7 Personal Exoskeleton in the U.S.April 15, 2025 | markets.businessinsider.comLifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. MarketApril 15, 2025 | globenewswire.comLake Street Reaffirms Their Buy Rating on Lifeward (LFWD)April 15, 2025 | markets.businessinsider.comLifeward Ltd. (LFWD): Among the Penny Stocks With Huge Upside Potential According to AnalystsMarch 23, 2025 | msn.comLifeward Stock Falls Despite FDA Clearance of ReWalk 7 ExoskeletonMarch 17, 2025 | zacks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeAMIX, IRIX, LFWD, and ICU Company DescriptionsAutonomix Medical NASDAQ:AMIX$1.30 -0.07 (-5.11%) Closing price 06/13/2025 03:56 PM EasternExtended Trading$1.32 +0.02 (+1.54%) As of 06/13/2025 07:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.SeaStar Medical NASDAQ:ICU$1.18 -0.06 (-4.84%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$1.20 +0.03 (+2.12%) As of 06/13/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.IRIDEX NASDAQ:IRIX$0.95 +0.01 (+0.64%) As of 06/13/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.ReWalk Robotics NASDAQ:LFWD$1.10 -0.04 (-3.51%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$1.14 +0.04 (+3.64%) As of 06/13/2025 05:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/09 - 06/13 Alphabet Enters a Bull Market: Is It Time to Buy? Ouster Soars 27% as DoD Grants First 3D LiDAR Approval for Drones Super Micro Computer Stock: 2 Levels Smart Money Is Watching Intel's Price Spikes: Noise, or the First Notes of a Turnaround? IBM Up 10 Days in a Row: What’s Driving the Winning Streak? SoFi Stock’s Next Test: Can It Justify Its Premium Valuation? Ignore the Noise—Samsara Stock Is Still a Strong Buy Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
